Mark Weinswig MBA ’07 is chief financial officer of Avinger, a leading developer of innovative treatments for peripheral artery disease. Weinswig brings extensive strategic and operational financial experience to the company, including almost 20 years in financial leadership positions in private and publicly traded technology companies.